Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Taiwan: the censoring and monitoring mechanism about the change of appearance of drug and package in taiwan.
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: TANG, Tzung Han (Community pharmacy, Taichung, China Taiwan)
- Co-author(s): Tzung Han Tang
Backgroundsome people make fake medicine sell to pharmacy and clinics in March 2017 in Taiwan. They used cheaper hypolipidemic drugs substituted for the more expensive kind. Taiwan's Food and Drug Administration (TFDA) was first alerted by a pharmacist that a batch of rosuvastatin, or marketed as Crestor®, manufactured by global biotechnology.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019